Cite
APA Citation
Tarantelli, C., Gaudio, E., Hillmann, P., Spriano, F., Rinaldi, A., Kwee, I., Cascione, L., Fabbro, D., Stathis, A., Zucca, E., Cmiljanovic, V., & Bertoni, F. (n.d.). the novel mTORC1/2 inhibitor PQR620 has in vitro and in vivo activity in lymphomas. European journal of cancer, 69, S38–. http://access.bl.uk/ark:/81055/vdc_100039473340.0x00000a